Kosé is developing personalized skin care using consumers’ own iPS cells via Global Cosmetic Industry

Kosé is partnering with I Peace, Inc. and Reju, Inc. to develop personalized beauty products comprising iPSF (an induced pluripotent stem [iPS] cell extract) derived from customers’ own blood-drawn cells.

This process will reportedly optimize dosages and textures for each consumer; finished products will reportedly be “provided through medical institutions under medical supervision,” per Kosé.

By the end of 2024, iPSF-based formulations will commence demonstrating testing in Japan.

Read more